MARKET WIRE NEWS

Almiralll, S.A. (LBTSF) Q4 2024 Earnings Call Transcript

Source: SeekingAlpha

2025-02-25 00:15:14 ET

Almiralll, S.A. (LBTSF)

Q4 2024 Earnings Call Transcript

February 24, 2025 04:00 AM ET

Company Participants

Pablo Divasson - Investor Relations

Carlos Gallardo - President & Chief Executive Officer

Karl Ziegelbauer - Chief Scientific Officer

Michael McClellan - Chief Financial Officer

Paolo Cionini - Chief Commercial Officer

Conference Call Participants

Shan Hama - Jefferies

Guilherme Sampaio - CaixaBank

Francisco Ruiz - BNP Paribas Exane

Alvaro Lenze - Alantra Equities

Alistair Campbell - RBC

Joaquín García-Quirós - JB Capital Markets

Jaime Escribano - Banco Santander

Presentation

Operator

Good day and thank you for standing by. Welcome to the Almirall Full Year 2024 Results and Business Update Conference Call. At this time all participants are in listen-only mode. After the speaker's presentation, there will be the question and answer session. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Pablo Divasson. Please go ahead.

Pablo Divasson

Thank you very much Nadia. Good morning everyone. Thank you for joining us for today's quarterly earnings update and review of Almirall's 2024 full year financial results. As always, we are sharing the slides we are using today in the Investors section of our website at almirall.com.

Please move to slide number two. Let me remind you that the information presented in this call contains forward-looking statements, which involve known and unknown risks, uncertainties and other factors that may cause actual results to materially differ from what we are sharing today. ...

Read the full article on Seeking Alpha

For further details see:

Almiralll, S.A. (LBTSF) Q4 2024 Earnings Call Transcript
Almirall SA

NASDAQ: LBTSF

LBTSF Trading

0.0% G/L:

$15.35 Last:

100 Volume:

$15.35 Open:

mwn-link-x Ad 300

LBTSF Latest News

LBTSF Stock Data

$3,214,193,663
209,393,724
N/A
N/A
Pharmaceuticals
Healthcare
ES

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App